✦ LIBER ✦

Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

✍ Scribed by Van Cutsem, E.; Kohne, C.-H.; Lang, I.; Folprecht, G.; Nowacki, M. P.; Cascinu, S.; Shchepotin, I.; Maurel, J.; Cunningham, D.; Tejpar, S.; Schlichting, M.; Zubel, A.; Celik, I.; Rougier, P.; Ciardiello, F.

Book ID: 127272778
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 219 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2010.33.5091

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6077 A meta-analysis of the CRYSTAL and

6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status

✍ Van Cutsem, E.; Rougier, P.; Köhne, C.; Stroh, C.; Schlichting, M.; Bokemeyer, C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

4004 Cetuximab plus capecitabine as firs

4004 Cetuximab plus capecitabine as first-line treatment for elderly patients (pts) with advanced colorectal cancer (mCRC). Final analysis of activity and survival according to KRAS status – the TTD-06–01 Spanish Cooperative Group trial

✍ F. Rivera; C. Gravalos; B. Massutí; J. Puente; E. Marcuello; M. Valladares; V. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB